today's volume and price inversion are a thing not seen in months.
and now it's on to the AACR annual event where imetelstat will be shown and most definitely talked about, so it's premature to write scarlett off on a come back.
I hate to see this stock flushed right down the old toilet.
But, that's exactly what's happening with current mis-management.
Don't kid yourself about the AACR. Not much is going to happen with GERN.
The big pharms simply do not care about 163L or GERN.
Of course, IMO.
Have you checked the after hours market? It down to $1.05.
'"after hours"....after schmours. Don't mean diddley.